亚洲美女av教学av,视频在线观看一爽

FDA Layoffs Affect Drug Approvals, Forcing Pharma Companies to Exploit Loopholes FDA FDA layoffs delay drug approvals, forcing Daré Bioscience to use regulatory loopholes to launch a female-use sildenafil cream, raising safety and oversight concerns.
New FDA Commissioner Takes Office FDA New FDA Commissioner Martin A. Makary takes office, announcing major reforms targeting rare disease drug approvals, aiming to streamline processes and enhance post-market surveillance.
Innovative Drugs: The Changing Times FDA Recent advancements in ADC therapies are reshaping cancer treatment. AstraZeneca and Gilead's breakthroughs in first-line therapies for breast and TNBC cancers mark a new era in innovative drug development.
Arsenic Trioxide for Leukemia Treatment Arsenic Trioxide Hong Kong researchers developed ARSENOL?, the first oral arsenic trioxide drug for APL treatment, achieving over 97% survival. Approved by FDA & EMA, it's set to revolutionize leukemia care globally.
FDA's New Policy: Ban on Industry Employees as Advisors FDA The FDA bans employees of regulated companies from voting on advisory committees to reduce conflicts of interest, enhance transparency, and rebuild public trust under new reforms by Commissioner Makary.
FDA to Phase Out Animal Testing: New Drug Development Methods Ahead FDA The FDA announces a major shift in drug testing, replacing traditional animal experiments with AI models, organoids, and cell-based methods to improve safety, speed up approvals, reduce costs, and promote animal welfare.
FDA Approvals Summary - March 2025 FDA Drug Approvals A summary of FDA drug approvals in March 2025, including new treatments for asthma, food allergies, osteoporosis, Prader-Willi syndrome, hemophilia, and more.
FDA Approves CtexliTM (chenodiol) for the Treatment of Rare Disease Cerebrotendinous Xanthomatosis FDA FDA approves CtexliTM (chenodiol) for the treatment of Cerebrotendinous Xanthomatosis (CTX), a rare genetic disorder affecting bile acid metabolism. CtexliTM is the first FDA-approved drug for CTX, offering a new treatment option for patients.
FDA Approved Summay - Januaray 2025 FDA Drug Approvals Explore FDA drug approvals from January 2025, including treatments for Crohn's disease, colorectal cancer, Alzheimer's, migraine, and more. Key approvals from Eli Lilly, Amgen, AstraZeneca, and others reshape patient care options.
FDA Approves Romvimza (Vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor FDA The FDA has approved Romvimza (Vimseltinib) for treating non-metastatic tenosynovial giant cell tumor (TGCT) in adults, offering a promising option for patients with severe or recurring disease who cannot undergo surgery.

< Pre 1 2 345 6 7 8...10 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水